Clinuvel Pharmaceuticals Ltd
F:UR9
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Clinuvel Pharmaceuticals Ltd
F:UR9
|
AU |
|
Vital Energy Inc
NYSE:VTLE
|
US |
|
Sandfire Resources Ltd
ASX:SFR
|
AU |
|
G
|
Grand Prix International PCL
SET:GPI
|
TH |
|
F
|
Firm Capital Mortgage Investment Corp
TSX:FC
|
CA |
|
Porch Group Inc
NASDAQ:PRCH
|
US |
|
W
|
Wesco International Inc
F:WP7
|
US |
|
A
|
Adhi Kartiko Pratama Tbk PT
IDX:NICE
|
ID |
|
W
|
Wesco International Inc
XMUN:WP7
|
US |
|
F
|
Fuyao Glass Industry Group Co Ltd
F:4FG
|
CN |
|
I
|
Indomobil Multi Jasa Tbk PT
IDX:IMJS
|
ID |
|
Harbour Digital Asset Capital Ltd
HKEX:913
|
HK |
|
D
|
DBS Group Holdings Ltd
XBER:DEVL
|
SG |
|
B
|
Braster SA
WSE:BRA
|
PL |
|
L
|
Lucara Diamond Corp
OTC:LUCRF
|
CA |
|
Otello Corporation ASA
OSE:OTEC
|
NO |
|
L
|
Linde PLC
XMUN:LIN
|
UK |
|
T
|
Teekay Corp
XHAM:TCD
|
BM |
|
L
|
Linde PLC
F:LIN
|
UK |
|
Crocs Inc
NASDAQ:CROX
|
US |
|
Life Corp
OTC:LIFCF
|
JP |
|
I
|
Idarado Mining Co
OTC:IDAM
|
US |
Wall St Price Targets
UR9 Price Targets Summary
Clinuvel Pharmaceuticals Ltd
According to Wall Street analysts, the average 1-year price target for UR9 is 12.72 EUR with a low forecast of 5.81 EUR and a high forecast of 25.9 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is UR9's stock price target?
Price Target
12.72
EUR
According to Wall Street analysts, the average 1-year price target for UR9 is 12.72 EUR with a low forecast of 5.81 EUR and a high forecast of 25.9 EUR.
What is the Revenue forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 39%. The projected CAGR for the next 8 years is 8%.
What is the Gross Profit forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
8%
The compound annual growth rate for Gross Profit over the next 8 years is 8%.
What is the Operating Income forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
9%
The compound annual growth rate for Operating Income over the next 8 years is 9%.
What is the Pre-Tax Income forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
20%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 20%.
What is the Net Income forecast for Clinuvel Pharmaceuticals Ltd?
Projected CAGR
11%
The compound annual growth rate for Net Income over the next 8 years is 11%.
